Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

By afschroeder • November 27, 2025

Khanna D, Spino C, Tashkin DP, Bernstein EJ, Goldin J, Kleerup EC, Harui A, Ibrahim G, Kim GHJ, Huang S, McLain R, Tu YH, Nagaraja V, Silver RM, Steen VD, Weigt SS, Lee JS, Fischer A, Scholand MB, Gordon JK, Dellaripa PF, Rosas IO, Hunninghake GM, Trojanowski MA, Simms RW, Dematte JE, Hsu VM, Domsic RT, Raghu G, Mayes MD, Boente RD, Roth MD; Scleroderma Lung Study III Investigators. Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. ACR Open Rheumatol. 2025 Dec;7(12):e70126. doi: 10.1002/acr2.70126. PMID: 41294296; PMCID: PMC12648624.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Patient Selection, Procedural Pearls, and Expected Outcomes

Lee L, Cao S, Miles CB, Troy MP, Moriarty JM. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Patient Selection, Procedural Pearls, and Expected Outcomes.[...]

Case Report: Exercise-associated changes of leukocyte gene expression in statin-associated myopathy

Bondar G, Mahapatra AD, Silacheva I, Bao TM, Vu T, Su S, Hairapetian A, Katappagari A, Galan L, Chandran J, Adamov R, Yang A, Bukkapatnam[...]

Clinical association between current depressive symptoms and odds ratio product in US sleep centers

Defillo A, Grassi M, Daccò S, Martin JL, Guadagni V. Clinical association between current depressive symptoms and odds ratio product in US sleep centers. Front[...]